Richard Zeifman

Richard Zeifman
Ph.D. Candidate — CPT+MDMA Study Clinician

About

Richard is enthusiastic about enhancing evidence-based interventions for mental health, which makes him especially excited to be working at Remedy as a research collaborator and trial therapist (Cognitive Processing Therapy + MDMA for PTSD). Richard Zeifman is a Ph.D. Candidate in Clinical Psychology at X University, a research associate at Imperial College London, and a psychology resident at the Centre for Addiction and Mental Health (CAMH).

Richard’s research focuses on optimizing psychotherapeutic interventions by (a) examining the mechanisms through which psychotherapeutic interventions lead to change and (b) integrating psychotherapies with novel pharmacological interventions (e.g., psilocybin, MDMA). His clinical work focuses on providing patient-centered cognitive behavioural and emotion-focused therapies for individuals with complex clinical presentations (e.g., posttraumatic stress disorder [PTSD], borderline personality disorder).